BOSTON LIFE SCIENCES INC /DE
10-Q, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: BOSTON LIFE SCIENCES INC /DE, 10-Q, 2000-11-14
Next: STURM RUGER & CO INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM FINANCIAL STATEMENTS
AS REPORTED ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       1,526,774
<SECURITIES>                                20,173,151
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            22,056,481
<PP&E>                                          54,903
<DEPRECIATION>                                   9,844
<TOTAL-ASSETS>                              22,295,832
<CURRENT-LIABILITIES>                        1,975,004
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       207,206
<OTHER-SE>                                  20,113,622
<TOTAL-LIABILITY-AND-EQUITY>                22,295,832
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                9,594,914
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             344,870
<INCOME-PRETAX>                            (9,199,586)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (9,199,586)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,199,586)
<EPS-BASIC>                                     (0.48)
<EPS-DILUTED>                                   (0.48)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission